Proprionate

Most of the fiber you eat passes through your small intestine undigested and reaches your colon, where bacteria ferment it. One of the main things they make is propionate (the salt form of propionic acid), a small fatty acid your body absorbs and uses for fuel and for chemical signaling. This test measures how much of it is left in your stool, which gives a rough picture of how that fermentation is going.

In research studies, people with active inflammatory bowel disease, worsening kidney function, or Parkinson's disease tend to have less of it in their stool than comparison groups. People with colorectal cancer tend to have lower stool short-chain fatty acids overall, though propionate itself is the least consistent of the group. This is still a research-grade measure with no agreed cutoffs, so most of its value comes from a baseline you can track over time and read alongside the other fermentation products on the same report.

What the Number Reflects

Gut bacteria make propionate mostly from fiber and resistant starch, with smaller amounts coming from protein. A large share comes from one broad group of bacteria, the Bacteroidetes. In a study of 57 adults, people whose gut communities were dominated by Prevotella bacteria ate diets linked to more acidic stool and more propionic acid production.

Most of the propionate your bacteria make is absorbed through the colon wall and carried to the liver. In a small human trial, the liver used gut-derived propionate to build a distinctive type of fat (odd-chain fatty acids) that tracks with fiber intake. Along the way, propionate acts on receptors on gut and immune cells, which is how it influences appetite hormones, immune balance, and the way your gut handles cholesterol.

So the stool number is a leftover. It reflects how much your bacteria produced minus how much your colon absorbed, and it's reported in micrograms per gram of stool. That makes it a fairly direct reading on fermentation in your colon and a much less direct one on how much propionate reaches the rest of your body.

Colorectal Cancer

Colorectal cancer is where stool short-chain fatty acids as a group have the most human research, but propionate on its own carries the weakest signal of the three main ones. A meta-analysis pools the results of many earlier studies into one estimate. One such analysis found that lower combined stool concentrations of acetic, propionic, and butyric acid went with higher risk and incidence of colorectal cancer, yet propionic acid had the most individual studies showing no difference between groups. A 2025 meta-analysis found lower stool butyrate and acetate in people with colorectal cancer and no difference in propionate. Another 2025 analysis concluded these fatty acids are protective as a group, with butyrate showing the strongest effect and results varying by ethnicity and by whether stool or blood was sampled.

What this means for you: a low propionate reading on its own says little about colorectal cancer risk, and butyrate and acetate on the same report are the more relevant numbers. Whatever this result shows, keep your colorectal screening on schedule. If you notice a change in bowel habits or blood in your stool, get a stool blood test and talk to a gastroenterologist about a colonoscopy.

Inflammatory Bowel Disease

Inflammatory bowel disease covers Crohn's disease and ulcerative colitis, conditions in which the immune system inflames the lining of the gut. Several meta-analyses found stool short-chain fatty acids are lower in people with these conditions, most clearly during active flares. In ulcerative colitis, concentrations were lower than in healthy people, though individual fatty acids moved inconsistently across disease stages, and one analysis found changes ran in opposite directions during active disease and remission.

For you, a low result alongside gut symptoms is a prompt to check for inflammation directly. Fecal calprotectin is the standard stool test for that question. It measures a protein that inflamed gut tissue releases, and it carries far more diagnostic weight than a fermentation marker does.

Kidney Function

In a small study of people with chronic kidney disease, lower stool propionate went along with worse results on the standard blood measures of kidney filtration (higher creatinine and urea, lower estimated filtration rate). The same research found that giving propionate to animals slowed the move from acute kidney injury to chronic disease and reduced kidney inflammation and scarring. That second finding comes from animal models, so the human takeaway is narrower.

If your stool level is low and you have kidney risk factors such as high blood pressure, diabetes, or a family history of kidney disease, check your kidney numbers directly with a blood test and a urine albumin test. The stool result can't tell you how your kidneys are filtering.

Parkinson's Disease and Mood

In a study of 181 people, those with Parkinson's disease had lower stool short-chain fatty acids but higher blood levels. Lower stool and higher blood propionate went along with an imbalanced gut bacterial community, a leakier gut lining, and worse movement and thinking scores.

In a study of 116 Polish women, those with depression had lower stool acetate, and propionate trended lower without reaching a firm result. Both are single-study associations. They suggest a link between gut fermentation and the brain, and neither makes a stool result a way to judge your risk of these conditions.

Allergies in Early Childhood

A systematic review found that higher levels of propionate and the other short-chain fatty acids in the first few years of life generally went with lower risk of eczema, wheeze or asthma, and food allergy. Much of that protective signal comes from butyrate, and in some cohorts valeric acid, rather than propionate alone. How a baby is fed also changes the picture: a meta-analysis found that stool fatty acid concentrations in the first year differ between breastfed, formula-fed, and mixed-fed infants. If you're testing a child, compare results only against children of a similar age and feeding stage.

Higher Levels and Metabolic Strain

Not every study points the same way. In 147 women going through in vitro fertilization, higher stool propionate went with lower odds of a clinical pregnancy and tracked with higher fasting insulin, higher triglycerides, and a higher insulin resistance score. A systematic review of stool short-chain fatty acids in metabolic disorders also linked elevated levels with obesity, inflammation, and an imbalanced gut bacterial community.

These findings fit with the colon cancer and kidney data once you remember what the stool number is. It's what your bacteria made minus what your colon absorbed, so a low level can mean weak fermentation, while a high level can mean an unusual bacterial mix or less absorption by the colon. That makes this a pattern marker, where meaning comes from reading the result with your other fermentation products, your symptoms, and your metabolic labs, and an unusual result at either end deserves a closer look.

Stool and Blood Are Different Measurements

Propionate measured in blood behaves differently, and studies of it don't carry over to this test. In a study of 1,253 people, lower blood propionate went with coronary artery disease even after accounting for standard risk factors. In a Chinese study following 3,414 adults, higher circulating short-chain fatty acids went with a higher risk of developing type 2 diabetes.

The Parkinson's study shows how far apart the two can be, with stool levels lower and blood levels higher in the same patients. A stool result describes fermentation in your colon and gives no reliable estimate of your blood level.

When Results Can Be Misleading

Stool fatty acids shift with what you've eaten recently and with the sample itself, which makes a single reading easy to misread.

• Recent diet changes: a few weeks of a new fiber supplement or a diet that cuts fermentable carbohydrates (low-FODMAP) can move the result. Keep your usual diet for several weeks before testing, and note any changes.
• Antibiotics: antibiotics reshape gut bacteria, and in one human study they changed the bacteria behind a related microbial compound. A test taken soon after a course probably won't reflect your usual state.
• How watery the sample is: the result is reported per gram of stool, so an unusually loose or hard sample can push the concentration up or down without any change in how much your bacteria produce.
• Lab method: labs measure stool fatty acids with different techniques and different reference groups, so numbers from two labs can't be compared directly.

Certain lab handling factors can also occasionally affect the result.

Tracking Your Trend

There are no standard cutoffs, and diet alone can shift the number, so one result is a weak basis for any decision. A series of results is more useful because it shows your own normal and whether it moves when something in your life changes.

Get a baseline, retest in 3 to 6 months if you change your diet or start a fiber supplement, and then test at least once a year. Use the same lab each time and collect under similar conditions, with your usual diet and no recent antibiotics.

Be careful about what a change means. A shift after you adjust your diet shows your gut bacteria responded, but the direction alone doesn't tell you whether the change helped your health. Watch propionate together with butyrate, acetate, and total short-chain fatty acids, because the balance between them says more than any one number.

What to Do With an Unusual Result

An unusual result is a reason to look for a cause with tests that carry more clinical weight. Start by retesting under stable conditions, then follow the pattern that fits you.

• Low, with gut symptoms: check fecal calprotectin and a stool blood test (the fecal immunochemical test). See a gastroenterologist if either is abnormal or your symptoms persist.
• Low, with no symptoms: keep colorectal screening current and look at the other fermentation products on the same report. If all of them are low, that points to low fermentation overall.
• Low, with kidney risk factors: check creatinine, cystatin C, and the urine albumin-to-creatinine ratio. See a nephrologist if those show reduced filtration or protein in the urine.
• High, with metabolic risk factors: check fasting insulin, HbA1c (your average blood sugar over about three months), triglycerides, and an insulin resistance score to see whether the metabolic strain seen in some studies applies to you.